| Optimization of HER3 expression imaging using affibody molecules: Influence of chelator for labeling with indium-111 SS Rinne, CD Leitao, B Mitran, TZ Bass, KG Andersson, V Tolmachev, ... Scientific reports 9 (1), 655, 2019 | 25 | 2019 |
| Influence of molecular design on the targeting properties of ABD-fused mono-and bi-valent anti-HER3 affibody therapeutic constructs M Altai, CD Leitao, SS Rinne, A Vorobyeva, C Atterby, S Ståhl, ... Cells 7 (10), 164, 2018 | 24 | 2018 |
| Molecular Design of HER3-Targeting Affibody Molecules: Influence of Chelator and Presence of HEHEHE-Tag on Biodistribution of 68Ga-Labeled Tracers C Dahlsson Leitao, SS Rinne, B Mitran, A Vorobyeva, KG Andersson, ... International Journal of Molecular Sciences 20 (5), 1080, 2019 | 23 | 2019 |
| Evaluation of the therapeutic potential of a HER3-binding affibody construct TAM-HER3 in comparison with a monoclonal antibody, seribantumab A Orlova, TZ Bass, SS Rinne, CD Leitao, M Rosestedt, C Atterby, ... Molecular Pharmaceutics 15 (8), 3394-3403, 2018 | 22 | 2018 |
| Comparative evaluation of affibody-and antibody fragments-based CAIX imaging probes in mice bearing renal cell carcinoma xenografts J Garousi, FJ Huizing, A Vorobyeva, B Mitran, KG Andersson, CD Leitao, ... Scientific Reports 9 (1), 14907, 2019 | 17 | 2019 |
| Increase in negative charge of 68Ga/chelator complex reduces unspecific hepatic uptake but does not improve imaging properties of HER3-targeting affibody … SS Rinne, C Dahlsson Leitao, J Gentry, B Mitran, A Abouzayed, ... Scientific Reports 9 (1), 17710, 2019 | 16 | 2019 |
| Evaluating the therapeutic efficacy of mono-and bivalent affibody-based fusion proteins targeting HER3 in a pancreatic cancer xenograft model C Dahlsson Leitao, S S. Rinne, M Altai, O Vorontsova, F Dunås, ... Pharmaceutics 12 (6), 551, 2020 | 11 | 2020 |
| Benefit of later-time-point PET imaging of HER3 expression using optimized radiocobalt-labeled affibody molecules SS Rinne, C Dahlsson Leitao, Z Saleh-Nihad, B Mitran, V Tolmachev, ... International Journal of Molecular Sciences 21 (6), 1972, 2020 | 9 | 2020 |
| Influence of residualizing properties of the radiolabel on radionuclide molecular imaging of HER3 using affibody molecules SS Rinne, T Xu, C Dahlsson Leitao, S Ståhl, J Löfblom, A Orlova, ... International Journal of Molecular Sciences 21 (4), 1312, 2020 | 9 | 2020 |
| Improved contrast of affibody-mediated imaging of HER3 expression in mouse xenograft model through co-injection of a trivalent affibody for in vivo blocking of … M Rosestedt, KG Andersson, SS Rinne, CD Leitao, B Mitran, A Vorobyeva, ... Scientific Reports 9 (1), 6779, 2019 | 8 | 2019 |
| HER3 PET Imaging: 68Ga-Labeled Affibody Molecules Provide Superior HER3 Contrast to 89Zr-Labeled Antibody and Antibody-Fragment-Based Tracers SS Rinne, CD Leitao, A Abouzayed, A Vorobyeva, V Tolmachev, S Ståhl, ... Cancers 13 (19), 4791, 2021 | 7 | 2021 |
| Targeting tumor cells overexpressing the human epidermal growth factor receptor 3 with potent drug conjugates based on affibody molecules SS Rinne, W Yin, AM Borras, A Abouzayed, CD Leitao, A Vorobyeva, ... Biomedicines 10 (6), 1293, 2022 | 4 | 2022 |
| Cloning of affibody libraries for display methods S Ståhl, LC Hjelm, CD Leitao, J Löfblom, H Lindberg Cold Spring Harbor Protocols, 2023 | 3 | 2023 |
| Generation of an anti-idiotypic affibody-based masking domain for conditional activation of EGFR-targeting AM Borras, CD Leitao, S Ståhl, J Löfblom New Biotechnology 73, 9-18, 2023 | 3 | 2023 |
| Selection of affibody molecules using phage display LC Hjelm, CD Leitao, S Ståhl, J Löfblom, H Lindberg Cold Spring Harbor Protocols, 2023 | 2 | 2023 |
| Selection of affibody molecules using staphylococcal display J Löfblom, LC Hjelm, CD Leitao, S Ståhl, H Lindberg Cold Spring Harbor Protocols, 2023 | 2 | 2023 |
| Display of a naïve affibody library on staphylococci for selection of binders by means of flow cytometry sorting CD Leitao, AM Borras, A Jonsson, M Malm, N Kronqvist, F Fleetwood, ... Biochemical and Biophysical Research Communications 655, 75-81, 2023 | 1 | 2023 |
| Conditionally activated affibody-based prodrug targeting EGFR demonstrates improved tumour selectivity CD Leitao, AM Borras, T Xu, M Oroujeni, Y Liu, C Westerberg, J Clinton, ... Journal of Controlled Release 357, 185-195, 2023 | 1 | 2023 |
| Engineering of Affibody Molecules S Ståhl, H Lindberg, LC Hjelm, J Löfblom, CD Leitao Cold Spring Harbor Protocols, 2023 | | 2023 |
| Selection of Affibody Molecules Using Escherichia coli Display CD Leitao, LC Hjelm, S Ståhl, J Löfblom, H Lindberg Cold Spring Harbor Protocols, 2023 | | 2023 |
